Graphite Bio, Inc. GRPH 深 滬
等待開盤 04-30 09:30:00 美东时间
3.18
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 3.18
- 總市值 18.52万
- 52周最高 22.61
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 6.8607
- 委 比 0.00%
- 總股本 5.82万
- 歷史最高 230.79
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.92
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors
Fulcrum Therapeutics announced that Dr. Josh Lehrer has joined its Board of Directors as an independent director. With over two decades of experience in clinical development, Dr. Lehrer has led the development of transformative therapies, including Oxbryta for sickle cell disease. His expertise in rare disease drug development will support Fulcrum's advancement of pociredir and its hematology pipeline. Dr. Lehrer expressed his commitment to helpi...
04-27 10:55
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
Lyell Immunopharma announced the closing of an additional $50 million equity private placement following the achievement of a clinical milestone for its CAR T-cell therapy rondecabtagene autoleucel. The company also appointed Smital Shah as Chief Financial and Business Officer.
03-09 12:00
Graphjet provides Nasdaq hearing update
Graphjet Technology CEO/CFO attended a hearing with the Nasdaq Hearing Panel, committing to file Q1-Q2 2025 10Qs by mid-September. The Panel will review the case and issue a decision within two weeks. The company will provide updates via press releases as developments unfold.
2025-07-17 21:20
Graphjet Technology Discloses Stay of Suspension and Nasdaq Hearing Date
Graphjet Technology received a notice from Nasdaq regarding its non-compliance with listing rules due to delayed filing of its 10-K and 10-Q reports. Trading of its shares will continue until the hearing on July 17, 2025. The company plans to address the issues at the upcoming hearing to avoid trading suspension.
2025-06-16 23:52
LENZ Therapeutics gains as eye therapy succeeds in late-stage trial
LENZ Therapeutics (NASDAQ:LENZ) added ~16% premarket Wednesday after announcing that its lead asset LNZ100 reached main goals in a Phase 3 program for treating presbyopia, or the loss of near vision. ...
2024-04-03 19:58
Lenz stock rallies 22% amid bullish note by Piper Sandler
Lenz Therapeutics (NASDAQ:LENZ) stock was up 22% in afternoon trading Wednesday in the wake of a bullish note on the company by Piper Sandler. Piper Sandler initiated coverage of the stock with an ove...
2024-03-28 03:22
Graphite Bio’s Strategic Merger and Rebranding to LENZ Therapeutics
The latest announcement is out from Graphite Bio (GRPH). On March 14, 2024, Gra...
2024-03-22 18:12
美股牛股 | 金山云隔夜涨28.6%！万国数据涨22%，传高瓴、博裕等拟投资其亚洲数据中心
金山云隔夜涨28.6%，摩根大通上调其评级；万国数据隔夜涨22.0%，传高瓴、博裕等拟投资万国数据亚洲数据中心>>
2024-03-12 19:32
GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdings Limited (NASDAQ: GDS) shares rose sharply in today’s pre-market trading.
2024-03-11 17:50
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2024-02-28 09:52
